DV
Dividend Vision

PTCT — PTC Therapeutics Inc.

PTC Therapeutics Inc. (PTCT)

Total return is 334.8% over the past 13.1 years, 175.8 points behind SPY at 510.6%. Its deepest 1-year drawdown was 27.2%.

This is a single-stock equity holding in PTC Therapeutics Inc., a biopharmaceutical company, rather than a diversified ETF portfolio. As a concentrated stock position with no distribution rate or dividend history, it generates no regular income for shareholders. This holding appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical sector, as it lacks the yield characteristics and diversification typical of dividend-focused funds.

PTCT key facts

Asset type
Stock
Asset class
Equity
Inception date
06/20/2013
Distribution frequency
None
Last close
$71.70
Market cap
$5,984,139,264
Average volume
564300.0
Beta
0.545
Payout ratio
0.0
P/E ratio
7.5163
Forward P/E
41.3223
EPS
$-0.67